Complement factor H supplementation rather than complete C3 knockout provides therapeutic benefits in IgA nephropathy

Area of Science:

• Nephrology
• Immunology
• Complement System Biology

Background:

• IgA nephropathy (IgAN) is the most common glomerulonephritis, marked by IgA deposition and complement activation via the alternative pathway.
• Complement dysregulation in IgAN can cause kidney injury but may also aid in clearing immune complexes.
• The dual role of complement in IgAN necessitates a nuanced therapeutic approach.

Purpose of the Study:

• To compare the effects of complete complement component 3 (C3) deficiency versus complement factor H (CFH) supplementation in murine models of IgA nephropathy.
• To investigate the therapeutic potential of targeted complement regulation in IgAN.

Main Methods:

• Utilized murine models of IgA nephropathy (IgAN).
• Compared outcomes in mice with complete C3 deficiency versus mice supplemented with CFH.
• Analyzed glomerular deposition, macrophage infiltration, inflammatory markers, proteinuria, and phagocytosis.
• Correlated findings with plasma CFH levels in IgAN patients.

Main Results:

• C3 deficiency prevented complement activation but paradoxically worsened IgAN pathology, increasing IgA deposition and inflammation.
• CFH supplementation reduced IgA and C3 deposition, inflammation, and proteinuria.
• CFH supplementation enhanced macrophage-mediated clearance of IgA immune complexes.
• Higher plasma CFH levels in IgAN patients correlated with reduced deposition and better complement regulation.

Conclusions:

• Complement plays a dual role in IgAN, contributing to both kidney injury and immune complex clearance.
• Targeted complement regulation with CFH supplementation offers superior therapeutic benefits over global complement inhibition (C3 knockout).
• CFH is identified as a promising therapeutic target for managing IgA nephropathy.